Experienced Management Team

Glen Travers

Executive Chairman

25 years experience building healthcare businesses, successfully taken several therapeutics and diagnostics to market, some partnered with major multinational pharmaceutical companies.
Co-founded and built biopharmaceutical company Cortecs to peak $1.2bn value, $0.5bn on departure, company shared royalties with Nobel Laureates for Helicobacter discovery.  Listed company in UK, Nasdaq, Australia.

Dr. Roger New

Chief Scientific Officer & Executive Director

Distinguished scientist with a background in biochemistry and immunology, 30 years of experience in drug delivery. Visiting Professor at Middlesex University and Senior Lecturer at King’s College London.
Devised three new systems for oral delivery of peptides and gained first positive human results with an oral insulin.
Previous head of research at Cortecs & a leading scientist at Biocompatibles.
Inventor of numerous formulation technologies.

Print | Sitemap
© 2021, Diabetology Ltd | Privacy Policy | Terms & Conditions | Copyright